Dianthus Therapeutics (DNTH) Revenue (2022 - 2025)

Dianthus Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $396000.0 for Q3 2025.

• In Q3 2025, Revenue fell 81.77% year-over-year to $396000.0; the TTM figure through Sep 2025 stood at $3.1 million (down 41.61% YoY), while the FY2024 annual figure was $6.2 million, up 120.63% from the prior year.
• Revenue was $396000.0 for Q3 2025 at Dianthus Therapeutics, up from $193000.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.2 million in Q3 2024 to a low of $193000.0 in Q2 2025.
• Historically, Revenue has averaged $1.0 million across 4 years, with a median of $1.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Revenue soared 211.27% in 2024, then tumbled 89.64% in 2025.
• A 4-year view of Revenue shows it stood at $1.2 million in 2022, then tumbled by 63.21% to $426000.0 in 2023, then jumped by 211.27% to $1.3 million in 2024, then sank by 70.14% to $396000.0 in 2025.
• The last three Revenue figures came in at $396000.0 (Q3 2025), $193000.0 (Q2 2025), and $1.2 million (Q1 2025), per Business Quant data.